amoxicillin/clarithromycin/vonoprazan
Jump to navigation
Jump to search
Indications
- treatment of Helicobacter pylori infection (FDA approved May 2022)
Adverse effects
- dysgeusia, diarrhea, abdominal pain, headache, nasopharyngitis, hypertension, vulvovaginal candidiasis
- Stevens-Johnson syndrome & toxic epidermal necrolysis
- C difficile-associated diarrhea
- QT prolongation (clarithromycin)
Notes
- available Fall 2022
More general terms
Components
- amoxicillin (Amoxil, Polymox, Larotid, Trimox, DisperMox, Moxatag, A-cillin)
- clarithromycin (Biaxin)
- vonoprazan
References
- ↑ Hamza Z Two New Regimens Win FDA Approval for H. Pylori Infection. Dual and triple vonoprazan-based treatments offer physicians another set of options. MedPage Today May 4, 2022 https://www.medpagetoday.com/gastroenterology/generalgastroenterology/98547